BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16619239)

  • 1. Long-range PCR facilitates the identification of PMS2-specific mutations.
    Clendenning M; Hampel H; LaJeunesse J; Lindblom A; Lockman J; Nilbert M; Senter L; Sotamaa K; de la Chapelle A
    Hum Mutat; 2006 May; 27(5):490-5. PubMed ID: 16619239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lynch syndrome: toward an increasingly complex picture. The case of PMS2.
    Calvello M; Bonanni B
    Eur J Cancer Prev; 2023 Sep; 32(5):413-414. PubMed ID: 36942845
    [No Abstract]   [Full Text] [Related]  

  • 3. PMS2 or PMS2CL? Characterization of variants detected in the 3' of the PMS2 gene.
    Bouras A; Lefol C; Ruano E; Grand-Masson C; Wang Q
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23193. PubMed ID: 37534630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Catalytic Lysine Residue Conserved Among GHKL ATPases: MutL, GyrB, and MORC.
    Fukui K; Fujii Y; Yano T
    J Mol Biol; 2024 May; 436(10):168575. PubMed ID: 38641238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-source bioinformatic pipeline to improve PMS2 genetic testing using short-read NGS data.
    Munté E; Feliubadaló L; Del Valle J; González S; Ramos-Muntada M; Balmaña J; Ramon Y Cajal T; Tuset N; Llort G; Cadiñanos J; Brunet J; Capellá G; Lázaro C; Pineda M
    J Mol Diagn; 2024 Jun; ():. PubMed ID: 38851388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes.
    Vaughn CP; Robles J; Swensen JJ; Miller CE; Lyon E; Mao R; Bayrak-Toydemir P; Samowitz WS
    Hum Mutat; 2010 May; 31(5):588-93. PubMed ID: 20205264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing.
    Bodian DL; McCutcheon JN; Kothiyal P; Huddleston KC; Iyer RK; Vockley JG; Niederhuber JE
    PLoS One; 2014; 9(4):e94554. PubMed ID: 24728327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.
    Senter L; Clendenning M; Sotamaa K; Hampel H; Green J; Potter JD; Lindblom A; Lagerstedt K; Thibodeau SN; Lindor NM; Young J; Winship I; Dowty JG; White DM; Hopper JL; Baglietto L; Jenkins MA; de la Chapelle A
    Gastroenterology; 2008 Aug; 135(2):419-28. PubMed ID: 18602922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes.
    Johnston JJ; Rubinstein WS; Facio FM; Ng D; Singh LN; Teer JK; Mullikin JC; Biesecker LG
    Am J Hum Genet; 2012 Jul; 91(1):97-108. PubMed ID: 22703879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refining the role of PMS2 in Lynch syndrome: germline mutational analysis improved by comprehensive assessment of variants.
    Borràs E; Pineda M; Cadiñanos J; Del Valle J; Brieger A; Hinrichsen I; Cabanillas R; Navarro M; Brunet J; Sanjuan X; Musulen E; van der Klift H; Lázaro C; Plotz G; Blanco I; Capellá G
    J Med Genet; 2013 Aug; 50(8):552-63. PubMed ID: 23709753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avoidance of pseudogene interference in the detection of 3' deletions in PMS2.
    Vaughn CP; Hart KJ; Samowitz WS; Swensen JJ
    Hum Mutat; 2011 Sep; 32(9):1063-71. PubMed ID: 21618646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of DNA mismatch repair by variants of uncertain significance in the PMS2 gene.
    Drost M; Koppejan H; de Wind N
    Hum Mutat; 2013 Nov; 34(11):1477-80. PubMed ID: 24027009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PMS2 gene mutational analysis: direct cDNA sequencing to circumvent pseudogene interference.
    Wimmer K; Wernstedt A
    Methods Mol Biol; 2014; 1167():289-302. PubMed ID: 24823786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of Lynch syndrome patients.
    van der Klift HM; Tops CM; Bik EC; Boogaard MW; Borgstein AM; Hansson KB; Ausems MG; Gomez Garcia E; Green A; Hes FJ; Izatt L; van Hest LP; Alonso AM; Vriends AH; Wagner A; van Zelst-Stams WA; Vasen HF; Morreau H; Devilee P; Wijnen JT
    Hum Mutat; 2010 May; 31(5):578-87. PubMed ID: 20186688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comprehensive Strategy for Accurate Mutation Detection of the Highly Homologous PMS2.
    Li J; Dai H; Feng Y; Tang J; Chen S; Tian X; Gorman E; Schmitt ES; Hansen TA; Wang J; Plon SE; Zhang VW; Wong LJ
    J Mol Diagn; 2015 Sep; 17(5):545-53. PubMed ID: 26320870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calibration of multiple in silico tools for predicting pathogenicity of mismatch repair gene missense substitutions.
    Thompson BA; Greenblatt MS; Vallee MP; Herkert JC; Tessereau C; Young EL; Adzhubey IA; Li B; Bell R; Feng B; Mooney SD; Radivojac P; Sunyaev SR; Frebourg T; Hofstra RM; Sijmons RH; Boucher K; Thomas A; Goldgar DE; Spurdle AB; Tavtigian SV
    Hum Mutat; 2013 Jan; 34(1):255-65. PubMed ID: 22949387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A massive parallel sequencing workflow for diagnostic genetic testing of mismatch repair genes.
    Hansen MF; Neckmann U; Lavik LA; Vold T; Gilde B; Toft RK; Sjursen W
    Mol Genet Genomic Med; 2014 Mar; 2(2):186-200. PubMed ID: 24689082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classifying Variants of Undetermined Significance in BRCA2 with protein likelihood ratios.
    Karchin R; Agarwal M; Sali A; Couch F; Beattie MS
    Cancer Inform; 2008; 6():203-16. PubMed ID: 19043619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease.
    Xiong HY; Alipanahi B; Lee LJ; Bretschneider H; Merico D; Yuen RK; Hua Y; Gueroussov S; Najafabadi HS; Hughes TR; Morris Q; Barash Y; Krainer AR; Jojic N; Scherer SW; Blencowe BJ; Frey BJ
    Science; 2015 Jan; 347(6218):1254806. PubMed ID: 25525159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry.
    Thompson BA; Goldgar DE; Paterson C; Clendenning M; Walters R; Arnold S; Parsons MT; Michael D W; Gallinger S; Haile RW; Hopper JL; Jenkins MA; Lemarchand L; Lindor NM; Newcomb PA; Thibodeau SN; ; Young JP; Buchanan DD; Tavtigian SV; Spurdle AB
    Hum Mutat; 2013 Jan; 34(1):200-9. PubMed ID: 22949379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.